Page last updated: 2024-08-25

technetium tc 99m dimercaptosuccinic acid and MEA 2a

technetium tc 99m dimercaptosuccinic acid has been researched along with MEA 2a in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cascone, E; Celentano, L; Klain, M; Lupoli, G; Salvatore, M; Sullo, P1

Other Studies

1 other study(ies) available for technetium tc 99m dimercaptosuccinic acid and MEA 2a

ArticleYear
111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:4 Suppl 1

    Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Medullary; Diagnostic Imaging; Female; Follow-Up Studies; Humans; Indium Radioisotopes; Iodine Radioisotopes; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neoplasm Recurrence, Local; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Succimer; Survival Rate; Technetium Tc 99m Dimercaptosuccinic Acid; Thyroid Neoplasms; Thyroidectomy

1995